Last reviewed: May 24, 2026

Last updated: May 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, you can build muscle while on GLP-1 therapy—but it requires intentional nutrition and exercise planning. GLP-1 medications slow gastric emptying and reduce appetite, which can inadvertently lead to muscle loss if protein intake and resistance training are not prioritized during treatment.

Muscle preservation on GLP-1 matters because unintended lean mass loss can slow metabolism and compromise long-term body composition. PlexusDx supports precision-wellness by helping patients understand their individual metabolic and genetic context before and during GLP-1 use, enabling more informed discussions with their healthcare providers.

Why GLP-1 Users Face Unique Muscle-Building Challenges

GLP-1 agonists reduce appetite and slow stomach emptying, making it harder to consume the protein and total calories needed for muscle synthesis. Research shows GLP-1 users without structured resistance training lose 20–30% of weight loss as lean mass, compared to 25% lean mass loss in typical caloric deficit.

Sarcopenia risk increases when appetite suppression outpaces intentional protein and calorie replacement. Older adults and those with lower baseline muscle mass face heightened vulnerability. Early intervention with a sports nutritionist or registered dietitian can mitigate this risk significantly.

Protein and Caloric Framework for Muscle Preservation on GLP-1

Adequate protein intake is the cornerstone of muscle retention during GLP-1 therapy. Because appetite is reduced, protein-dense, calorie-efficient foods and strategic meal timing become critical. The table below outlines recommended intake ranges and practical strategies for GLP-1 users.

Nutritional Factor Recommended Target Practical Strategy
Daily Protein Intake 1.2–2.0g per kg body weight Distribute across 3–4 meals; use high-protein shakes or Greek yogurt
Total Daily Calories Modest deficit or maintenance Track intake; avoid aggressive deficits (>500 cal/day)
Meal Frequency 3–4 smaller meals Reduces nausea; improves protein distribution; aids satiety
Micronutrient Focus Iron, B12, folate, calcium Monitor via bloodwork; supplement if deficient; supports muscle recovery

Resistance Training and Progressive Overload on GLP-1

Progressive resistance training—2–3 sessions per week targeting all major muscle groups—is essential for muscle synthesis on GLP-1. Studies show GLP-1 users who combine resistance training with adequate protein lose less lean mass than those relying on aerobic exercise alone.

Start conservatively and increase weight or reps gradually. GLP-1 may lower energy levels initially, so shorter, high-intensity sessions (30–45 minutes) often work better than prolonged workouts. Recovery nutrition immediately post-exercise amplifies protein synthesis.

Medical Supervision and Monitoring: Who Should Adjust Their Approach

Not all GLP-1 users are candidates for intensive muscle-building protocols. Older adults, those with cardiovascular disease, kidney disease, or severe gastrointestinal symptoms should consult their provider before starting resistance training. A baseline metabolic assessment and body composition scan help establish realistic targets.

Regular check-ins with your healthcare provider—every 4–8 weeks—allow monitoring of weight loss velocity, muscle mass trends, and nutritional status. Bloodwork tracking folate, B12, iron, and albumin helps detect nutritional gaps early. Your provider may adjust GLP-1 dosing or recommend dietitian referral if muscle loss exceeds 5–10% per month.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around your individual metabolic and appetite-regulation pathways. Variants in genes like GLP1R, FTO, and MC4R can influence how your body responds to GLP-1 therapy and your baseline muscle-building capacity. This information should be interpreted with a qualified healthcare provider to inform personalized nutrition and training strategies.

The genetic test reveals predispositions in peptide signaling pathways—not exact medication response or guaranteed muscle-building outcomes. For example, certain FTO variants may correlate with higher appetite baseline, while specific GLP1R variants may influence satiety response. These insights can support a conversation about whether more aggressive protein supplementation or dietitian involvement is warranted.

When combined with body composition assessment and bloodwork, genetic context helps your provider develop a muscle-preservation plan tailored to your biology rather than generic recommendations. This precision approach can optimize your GLP-1 experience and help you maintain long-term health.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves